Split History
ETFs Holding ANTH »    ANTH Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Anthera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that benefit patients with unmet medical needs. Co. has two product candidates, Sollpura, and blisibimod. Sollpura™ is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, nephropathy, systemic lupus erythematosus, or lupus, lupus nephritis, and others. According to our ANTH split history records, Anthera Pharmaceuticals has had 3 splits.
ANTH split history picture
Anthera Pharmaceuticals (ANTH) has 3 splits in our ANTH split history database. The first split for ANTH took place on July 15, 2013. This was a 1 for 8 reverse split, meaning for each 8 shares of ANTH owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split. ANTH's second split took place on April 28, 2017. ANTH's third split took place on May 01, 2017. This was a 1 for 8 reverse split, meaning for each 8 shares of ANTH owned pre-split, the shareholder now owned 1 share. For example, a 125 share position pre-split, became a 15.625 share position following the split.

When a company such as Anthera Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ANTH split history from start to finish, an original position size of 1000 shares would have turned into 15.625 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Anthera Pharmaceuticals shares, starting with a $10,000 purchase of ANTH, presented on a split-history-adjusted basis factoring in the complete ANTH split history. ANTH split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/01/2010
End date: 05/24/2017
Start price/share: $448.64
End price/share: $1.70
Dividends collected/share: $0.00
Total return: -99.62%
Average Annual Total Return: -53.74%
Starting investment: $10,000.00
Ending investment: $37.89
Years: 7.23
Date Ratio
07/15/20131 for 8
04/28/20171 for 1
05/01/20171 for 8
ANTH is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

APEN Split History
APHB Split History
APPY Split History
APRI Split History
ARA Split History
ARTC Split History
ARWR Split History
ASMB Split History
ASTM Split History
ATE Split History

Xerox Corporation (XRX)
Waste Connections, Inc. (WCN)
Spark Energy, Inc. (SPKE)
MagneGas Corporation (MNGA)
Frontier Communications Corporation (FTR)
NeuroMetrix, Inc. (NURO)
Pain Therapeutics, Inc. (PTIE)
Rex Energy Corporation (REXX)
Rexahn Pharmaceuticals, Inc. (RNN)
Dataram Corporation (DRAM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ANTH Insider Buying

ANTH Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.